Table 2. Screening structural analogs of NPD387.
Compound | R1 | R2 | R3 | IC50 (μmol/L) |
|
---|---|---|---|---|---|
No Brij-35 | 0.01% Brij-35 | ||||
NPD387 | H | 11.84±0.57 | 18.27±1.46 | ||
CAS0006-E009 | * | * | * | 2.13±0.20 | 31.02±1.54 |
NPLC1171 | # | # | # | 48.63±2.36 | – |
NPLC1174 | Me | – | – | ||
NPD389 | H | 4.63±0.36 | 5.59±0.38 | ||
Bq | H | H | H | 8.34±0.71 | 7.32±2.31 |
Embelin | H | H | 52.40±3.88 | 110.68±4.77 | |
E-20 | H | – | – | ||
E-38 | H | H | 184.61±6.97 | 103.78±5.60 | |
E-39 | H | 69.23±3.09 | – | ||
E-40 | H | – | – | ||
E-42 | H | – | – | ||
E-47 | H | – | – | ||
E-48 | H | H | – | 158.74±8.24 | |
E-57 | H | H | 17.43±1.17 | 23.17±1.50 | |
E-59 | H | H | 18.59±1.25 | 34.09±3.28 |